Trial Profile
The effectiveness of switching from tiotropium/indacaterol to glycopyrronium/indacaterol combination in patients with COPD.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 May 2018
Price :
$35
*
At a glance
- Drugs Glycopyrrolate/indacaterol (Primary) ; Indacaterol; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 01 May 2018 Status changed from recruiting to completed.
- 05 May 2015 New trial record